APA (7th ed.) Citation

D, A., RW, W., J, W., R, P., N, M., SR, W., . . . RA, G. (2008). Dual inhibition of VEGFR and EGFR signaling reduces the incidence and size of intestinal adenomas in Apc(Min/+) mice. Molecular cancer therapeutics, 7(3), 590. https://doi.org/10.1158/1535-7163.MCT-07-0433

Chicago Style (17th ed.) Citation

D, Alferez, et al. "Dual Inhibition of VEGFR and EGFR Signaling Reduces the Incidence and Size of Intestinal Adenomas in Apc(Min/+) Mice." Molecular Cancer Therapeutics 7, no. 3 (2008): 590. https://doi.org/10.1158/1535-7163.MCT-07-0433.

MLA (9th ed.) Citation

D, Alferez, et al. "Dual Inhibition of VEGFR and EGFR Signaling Reduces the Incidence and Size of Intestinal Adenomas in Apc(Min/+) Mice." Molecular Cancer Therapeutics, vol. 7, no. 3, 2008, p. 590, https://doi.org/10.1158/1535-7163.MCT-07-0433.